Why Join Intellia?
Our mission is to develop curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.
Beyond our science, we live our four core values: One, Explore, Disrupt, Deliver and feel strongly that you can achieve more at Intellia. We have a single-minded determination to excel and succeed together. We believe in the power of curiosity and pushing boundaries. We welcome challenging thoughts and imagination to develop innovative solutions. And we know that patients are counting on us to make the promise a reality, so we must maintain high standards and get it done.
We want all of our people to go beyond what is possible. We aren’t constrained by typical end rails, and we aren’t out to just “treat” people. We’re all in this for something more. We’re driven to cure and motivated for change. Just imagine the possibilities of what we can do together.
How you will Achieve More with Intellia
In this Senior Process Development Scientist role, you will be responsible for developing and characterizing mRNA enzymatic processes in support of the late-stage development for our lead in vivo gene editing therapeutic candidates. To this end, you will leverage your upstream process and biochemistry experience to fully harness the power of enzymes to synthesize Nucleic Acids. As a process lead, you will help advance our gene-editing candidates such as NTLA2001 into a commercial process. You will also explore the broad spectrum of enzymatic process work to develop and scale-up next-generation nucleic acid therapeutics in support of Intellia’s platform technologies. In addition to lab responsibilities, you will be expected to actively participate in cross-functional and CMC teams as a lead SME.
If you've worked in process development and CMC teams to advance large molecule drug substances or cell therapeutics into late-stage clinical studies, you are an ideal candidate for this role! Additionally, your experience working with enzymes and your understanding of the basic principles and analytical techniques necessary to characterize enzyme function will enable you to be successful. Ideally, your training will include a Bachelor’s degree in Biochemistry, Biology, or related area with 10 – 12 years, a master’s degree with 6-8 years, or a Ph.D. with 2 – 4 years of hands-on industrial experience. Most importantly, if you have an enthusiastic curiosity to develop mRNA processes and learn about the future of medicine in gene editing, we strongly encourage you to apply!
Meet your future team
The Nucleic Acid Process Sciences team is a fun and energetic team of scientists focused on the internal development of nucleic acid therapeutics to create the curative gene-editing technologies of the future. As a team, we drive the late-stage development of Intellia’s mRNA DS for Intellia’s lead programs. Furthermore, we are responsible for the development of enzymatic process and characterization tools to build a wide range of nucleic acid modalities for Intellia’s next-generation platform technologies. We have an interesting and diverse background and set of experiences reflecting the breadth and depth of our responsibilities, and we look forward to meeting and welcoming onboard the next member of the team!
EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.